$GLTO
Galecto, Inc.

2021 Q4 Form 10-Q Financial Statement

#000156459021054462 Filed on November 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.353M $3.191M $2.520M
YoY Change -5.55% 26.63% 119.13%
% of Gross Profit
Research & Development $10.12M $9.748M $7.651M
YoY Change 30.52% 27.41% 108.25%
% of Gross Profit
Depreciation & Amortization $7.000K $8.000K
YoY Change
% of Gross Profit
Operating Expenses $13.47M $12.94M $10.17M
YoY Change 19.19% 27.28% 176.7%
Operating Profit -$12.94M -$10.17M
YoY Change 27.28% -310.65%
Interest Expense $59.00K $243.0K -$1.490M
YoY Change -121.07% -116.31% -538.24%
% of Operating Profit
Other Income/Expense, Net $243.0K -$1.485M
YoY Change -116.36% -305.96%
Pretax Income -$13.41M -$12.70M -$11.65M
YoY Change 15.79% 8.98% 183.45%
Income Tax
% Of Pretax Income
Net Earnings -$13.41M -$12.70M -$11.65M
YoY Change 15.79% 8.97% 183.82%
Net Earnings / Revenue
Basic Earnings Per Share -$0.50
Diluted Earnings Per Share -$530.8K -$502.6K -$461.2K
COMMON SHARES
Basic Shares Outstanding 25.26M 25.26M
Diluted Shares Outstanding 25.26M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $100.2M $102.1M $85.30M
YoY Change -38.76% 19.75%
Cash & Equivalents $62.56M $66.16M $85.33M
Short-Term Investments $37.63M $35.99M
Other Short-Term Assets $2.062M $365.0K $1.000M
YoY Change 14.56% -63.5%
Inventory
Prepaid Expenses
Receivables $5.569M $3.330M $2.900M
Other Receivables $2.280M $1.169M $6.900M
Total Short-Term Assets $110.1M $107.0M $96.10M
YoY Change -34.97% 11.34%
LONG-TERM ASSETS
Property, Plant & Equipment $203.0K $214.0K $900.0K
YoY Change -77.44% -76.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $9.048M $25.49M
YoY Change
Other Assets $2.028M $1.364M $200.0K
YoY Change 74.53% 582.0%
Total Long-Term Assets $12.12M $28.87M $2.054M
YoY Change 427.66% 1305.74%
TOTAL ASSETS
Total Short-Term Assets $110.1M $107.0M $96.10M
Total Long-Term Assets $12.12M $28.87M $2.054M
Total Assets $122.2M $135.9M $98.15M
YoY Change -28.78% 38.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.531M $1.981M $4.463M
YoY Change -46.3% -55.61%
Accrued Expenses $3.013M $3.762M $3.818M
YoY Change 10.98% -1.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.500M $5.700M $8.281M
YoY Change -19.64% -31.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $448.0K $511.0K $600.0K
YoY Change -10.4% -14.83%
Total Long-Term Liabilities $448.0K $511.0K $600.0K
YoY Change -10.4% -14.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.500M $5.700M $8.281M
Total Long-Term Liabilities $448.0K $511.0K $600.0K
Total Liabilities $4.992M $6.254M $8.870M
YoY Change -18.26% -29.49%
SHAREHOLDERS EQUITY
Retained Earnings -$156.1M -$142.7M -$92.78M
YoY Change 49.59% 53.8%
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $117.2M $129.6M -$91.74M
YoY Change
Total Liabilities & Shareholders Equity $122.2M $135.9M $98.15M
YoY Change -28.78% 38.43%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$13.41M -$12.70M -$11.65M
YoY Change 15.79% 8.97% 183.82%
Depreciation, Depletion And Amortization $7.000K $8.000K
YoY Change
Cash From Operating Activities -$17.83M -$9.159M -$8.580M
YoY Change 22.87% 6.75% 54.04%
INVESTING ACTIVITIES
Capital Expenditures $4.000K -$47.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $14.41M $7.094M
YoY Change
Cash From Investing Activities $14.41M $7.047M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 55.93M
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -17.83M -9.159M -8.580M
Cash From Investing Activities 14.41M 7.047M
Cash From Financing Activities 0.000 0.000 55.93M
Net Change In Cash -3.417M -2.112M 47.35M
YoY Change -104.42% -104.46% -950.09%
FREE CASH FLOW
Cash From Operating Activities -$17.83M -$9.159M -$8.580M
Capital Expenditures $4.000K -$47.00K
Free Cash Flow -$17.83M -$9.112M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Assets Current
AssetsCurrent
107008000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66157000
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q4 us-gaap Assets Current
AssetsCurrent
169295000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14364000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38343000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30908000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.50
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-55.25
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.52
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-118.89
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25261832
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
259966
CY2021Q3 glto Debt Securities Available For Sales Type Extensible List
DebtSecuritiesAvailableForSalesTypeExtensibleList
us-gaap:CorporateDebtSecuritiesMember
CY2021Q3 us-gaap Debt Securities Available For Sale Maturity Allocation Extensible List
DebtSecuritiesAvailableForSaleMaturityAllocationExtensibleList
http://fasb.org/us-gaap/2021-01-31#DebtSecuritiesMaturityAllocationContractualMaturityMember
CY2021Q3 glto Operating Lease Liability Current Statements Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementsOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiabilityCurrent
CY2020Q4 glto Operating Lease Liability Current Statements Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementsOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiabilityCurrent
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y8M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P9Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
163582000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25261832
CY2020Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2713000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
7648000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12696000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25261832
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
259966
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-369000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2331000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-740000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2136000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001800315
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Entity Registrant Name
EntityRegistrantName
GALECTO, INC.
dei Trading Symbol
TradingSymbol
GLTO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25261832
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39655
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1957007
dei Entity Address Address Line1
EntityAddressAddressLine1
75 State Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02109
dei City Area Code
CityAreaCode
+45
dei Local Phone Number
LocalPhoneNumber
70 70 52 10
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5743000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5566000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
511000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
541000
CY2021Q3 us-gaap Liabilities
Liabilities
6254000
CY2020Q4 us-gaap Liabilities
Liabilities
6107000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1981000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2851000
CY2021Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
3762000
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2715000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
885000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
214000
CY2021Q3 us-gaap Assets
Assets
135874000
CY2020Q4 us-gaap Assets
Assets
171596000
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25261832
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25261832
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25261832
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
272412000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
269175000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-142703000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104360000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-89000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
674000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
129620000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
165489000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
135874000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9748000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7651000
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10166000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12939000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4864000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5713000
CY2021Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
25492000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
940000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q3 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
856000
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
254000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1364000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1162000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
171596000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28373000
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
35987000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16874000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3191000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2515000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10386000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5461000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
12939000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
10166000
us-gaap Operating Expenses
OperatingExpenses
38759000
us-gaap Operating Expenses
OperatingExpenses
22335000
us-gaap Operating Income Loss
OperatingIncomeLoss
-38759000
us-gaap Operating Income Loss
OperatingIncomeLoss
-22335000
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
35000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
126000
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
208000
CY2020Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1485000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
290000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-925000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
243000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1485000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
416000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-925000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-12696000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-11651000
us-gaap Net Income Loss
NetIncomeLoss
-38343000
us-gaap Net Income Loss
NetIncomeLoss
-23260000
CY2021Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
34000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-23000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
535000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2136000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-335000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2331000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-763000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2136000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13031000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9320000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39106000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21124000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
141432000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1219000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-369000
CY2021Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
34000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-12696000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
129620000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-82551000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
134000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2331000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-11651000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-91737000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
165489000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3237000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-740000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-23000
us-gaap Net Income Loss
NetIncomeLoss
-38343000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
129620000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-71148000
us-gaap Net Income Loss
NetIncomeLoss
-23260000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-91737000
us-gaap Profit Loss
ProfitLoss
-38343000
us-gaap Profit Loss
ProfitLoss
-23260000
us-gaap Depreciation
Depreciation
13000
us-gaap Share Based Compensation
ShareBasedCompensation
3237000
us-gaap Share Based Compensation
ShareBasedCompensation
507000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-731000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
317000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
136000
glto Accretion Of Lease Liability
AccretionOfLeaseLiability
57000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-849000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
220000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
856000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
865000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
203000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-871000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1134000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
993000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1019000
glto Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-403000
glto Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-99000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34479000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23686000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
84209000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
21976000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
227000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-62460000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
163836000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11525000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
95599000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-96939000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
71913000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-740000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2136000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66157000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85574000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66157000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85333000
CY2020Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
241000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66157000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85574000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
40000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
409000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
672000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-142700000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-12700000
us-gaap Profit Loss
ProfitLoss
-38300000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-11700000
us-gaap Profit Loss
ProfitLoss
-23300000
CY2021Q3 us-gaap Investments And Cash
InvestmentsAndCash
127600000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
107000000.0
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5700000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
163600000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
169300000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5600000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
35987000
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
35987000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
25492000
CY2021Q3 us-gaap Long Term Investments
LongTermInvestments
25492000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
35990000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
35987000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
25512000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
25492000
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
61502000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
61479000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.57
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
227000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
214000
CY2021Q3 us-gaap Depreciation
Depreciation
8000
us-gaap Depreciation
Depreciation
13000
CY2020 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0
CY2021Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
113192000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
142904000
CY2021Q3 glto Contract Research And Development Cost Current
ContractResearchAndDevelopmentCostCurrent
3330000
CY2020Q4 glto Contract Research And Development Cost Current
ContractResearchAndDevelopmentCostCurrent
1620000
CY2021Q3 glto Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
856000
CY2020Q4 glto Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
1808000
CY2021Q3 us-gaap Prepaid Insurance
PrepaidInsurance
171000
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1642000
CY2021Q3 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
313000
CY2020Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
401000
CY2021Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
194000
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
242000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4864000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5713000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.50
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.890
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2061624
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3619586
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-55.25
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
6.67
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
130000
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
65000
us-gaap Operating Lease Cost
OperatingLeaseCost
374000
us-gaap Operating Lease Cost
OperatingLeaseCost
136000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
142000
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
67000
us-gaap Operating Lease Payments
OperatingLeasePayments
403000
us-gaap Operating Lease Payments
OperatingLeasePayments
136000
CY2021Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
409000
CY2020Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
420000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
409000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
672000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
118000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
438000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
267000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
208000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
17000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1048000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
108000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
940000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.52
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3923728
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2022000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1031000
CY2021Q3 glto Contract Research And Development Costs Current
ContractResearchAndDevelopmentCostsCurrent
925000
CY2020Q4 glto Contract Research And Development Costs Current
ContractResearchAndDevelopmentCostsCurrent
967000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
428000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
374000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
387000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
343000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3762000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2715000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
304142
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.58
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2235285
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.67
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1016
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.95
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2538411
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.67
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
20009769
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1556000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.79
glto Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
8160
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
170683
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.63
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-12696000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
2061624
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-11651000
us-gaap Net Income Loss
NetIncomeLoss
-23260000
us-gaap Net Income Loss
NetIncomeLoss
-38343000
CY2020Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2713000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
7648000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12696000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14364000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38343000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30908000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1266116
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.97
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1173185
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1219000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
134000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3237000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
507000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.007
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.004
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.905
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-118.89
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25261832
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
259966
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25261832
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
259966

Files In Submission

Name View Source Status
0001564590-21-054462-index-headers.html Edgar Link pending
0001564590-21-054462-index.html Edgar Link pending
0001564590-21-054462.txt Edgar Link pending
0001564590-21-054462-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
glto-10q_20210930.htm Edgar Link pending
glto-10q_20210930_htm.xml Edgar Link completed
glto-20210930.xsd Edgar Link pending
glto-20210930_cal.xml Edgar Link unprocessable
glto-20210930_def.xml Edgar Link unprocessable
glto-20210930_lab.xml Edgar Link unprocessable
glto-20210930_pre.xml Edgar Link unprocessable
glto-ex311_8.htm Edgar Link pending
glto-ex312_6.htm Edgar Link pending
glto-ex321_7.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending